Debra A. Benator, MD, FACP, FIDSA

Dr. Benator
Title:
Professor, Department of Medicine, George Washington University; Director, HIV-Infectious Diseases Clinic, DC Veterans Affairs Medical Center
Office:
151B
Address:
50 Irving Street NW
Washington, District Of Columbia 20422
Phone:
202-745-8301
Email:
[email protected]
Website:
Faculty Profile

Current HIV/AIDS Research Activities:

  • Principal Investigator, Tuberculosis Trials Consortium under MOU with the Centers For Disease Control and Prevention, Division of TB Elimination:  Lead of Partnership with Stellenbosch University, Cape Town, South Africa
  •  Principal Investigator: DC VAMC Site, DC Cohort, Development of A City-Wide Cohort Of HIV-Infected Persons In Care In The District Of Columbia. (PI Alan Greenberg and  Amanda Castel GWU Epidemiology and Biostatistics)
  • Co- Principal Investigator:  DC VAMC: Family Centered Advanced Directives in People Living With HIV: (PI: Maureen Lyon Ph.D., Children's National Medical Center)  

Current HIV/AIDS Educational Activities:

  • Director, GWUMC/VAMC Infectious Diseases Fellowship VA Outpatient HIV/ID Clinic Teaching Program 
  • Teaching Attending, HIV-Infectious Diseases  Fellow Clinics and Medicine Resident Clinics
  • Attending, Infectious Diseases Inpatient Consult Service
  • Teaching Faculty GWU Medical School Microbiology Course:  Tuberculosis and Nontuberculous Mycobacteria
  • Director and Teacher, Twice Weekly didactic for ID Fellows:  Antiretroviral therapy and treatment of HIV Infection

Current HIV/AIDS Clinical Activities:

  • Clinic Director for the HIV-Infectious Diseases Clinic at the VAMC in Washington DC where HIV and primary care is provided for approximately 1150 patients with HIV infection
  • Treatment of Hepatitic C among HIV-Hepatitis C co-infected  and Hepatitis C mono-infected individuals
  • Associate Director of Infection Control with oversight of HIV and Hepatitis Blood Borne Exposures, TB evaluation and TB isolation
  • Director of DC VAMC Directly Observed Therapy Program for Treatment of Latent TB Infection with 12 weekly doses of isoniazid and rifapentine